172 related articles for article (PubMed ID: 6546895)
1. The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.
Peden NR; Hart IR
Can Med Assoc J; 1984 May; 130(9):1141-4. PubMed ID: 6546895
[TBL] [Abstract][Full Text] [Related]
2. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.
Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K
Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550
[TBL] [Abstract][Full Text] [Related]
3. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Kaplowitz PB; Jiang J; Vaidyanathan P
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
5. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
6. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
[TBL] [Abstract][Full Text] [Related]
7. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
8. Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
Ross DS; Daniels GH; De Stefano P; Maloof F; Ridgway EC
J Clin Endocrinol Metab; 1983 Aug; 57(2):250-3. PubMed ID: 6688081
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
10. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
[TBL] [Abstract][Full Text] [Related]
12. Transient Hypothyroidism after Radioiodine for Graves' Disease: Challenges in Interpreting Thyroid Function Tests.
Sheehan MT; Doi SA
Clin Med Res; 2016 Mar; 14(1):40-5. PubMed ID: 26864507
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
[TBL] [Abstract][Full Text] [Related]
14. Compensated low-dose 131I therapy of Graves' disease.
Roudebush CP; Hoye KE; DeGroot LJ
Ann Intern Med; 1977 Oct; 87(4):441-3. PubMed ID: 578665
[TBL] [Abstract][Full Text] [Related]
15. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism.
Kung AW; Yau CC; Cheng AC
Thyroid; 1995 Feb; 5(1):7-12. PubMed ID: 7787438
[TBL] [Abstract][Full Text] [Related]
16. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Chen JJ; Ladenson PW
J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
[TBL] [Abstract][Full Text] [Related]
17. Outcome following radioactive iodine therapy in Graves' disease.
Chen JY; Huang HS; Huang MJ; Lin JD; Juang JH; Huang BY; Wang PW; Liu RT
Changgeng Yi Xue Za Zhi; 1990 Dec; 13(4):258-67. PubMed ID: 2282562
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
19. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
[TBL] [Abstract][Full Text] [Related]
20. Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves' disease.
Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Hansen BM; Søe-Jensen P; Hansen JM
J Intern Med; 1995 Dec; 238(6):491-7. PubMed ID: 9422034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]